As a result, TRAP1 boosts an aggressive pseudo-hypoxic phenotype, and its increased expression correlates with disease progression and poor prognosis in diverse cancer types [4], whereas TRAP1 genetic or pharmacological inhibition impedes the growth of various neoplastic models [16–18]. This evidence concerns the gene TRAP1 and cancer.